December 5, 2017
Probiodrug and Crossbeta Biosciences extend their strategic partnership in the field of Alzheimer’s disease biomarkers
Probiodrug, a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer’s disease (AD), and the Dutch biotech company Crossbeta Biosciences have extended their strategic…